Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Stock indices exist to track market performance and guide investment decisions. Learn their purpose, construction, and practical uses.
22,537 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Crypto exchanges are expanding into US stocks and tokenized equities, launching a two-front challenge to traditional ...
SpaceX stock SPCX rebounds after a three-day selloff, with traders awaiting new catalysts as analysts weigh long-term...
Chipotle faces its first full year of negative comps while McDonald’s leads with traffic recovery and value pricing. ...
Conagra (CAG) faces a pivotal year as 2026 earnings hinge on pricing, cost control, and portfolio focus. This analysi...
Hims & Hers Health shares surged in premarket trading after reports they ended a dispute with Novo Nordisk by forging...
Rocket Lab is tightening revenue visibility with a growing backlog and stronger margins entering 2026. Analysts eye h...
NVIDIA posted blockbuster results that reinforce its AI data center leadership, but the stock faces a rocky road as h...
Analysts see a path for Intel to reach higher stock levels by 2028 if its foundry expansion and AI data-center moment...
In Q1 2026, Tepper’s Appaloosa slashed its Microsoft stake by about 82%, while Bill Ackman’s Pershing Square bought r...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Two industry giants released mixed Q1 results, highlighting divergent paths for July. Lockheed Martin stays mission-f...